Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial experience with beta blockers in dilated cardiomyopathy

K Swedberg1

  • 1Department of Medicine, Ostra Hospital, University of Göteborg, Sweden.

The American Journal of Cardiology
|March 25, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM) Study Programme.

Blood pressure·2017
Same author

Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.

QJM : monthly journal of the Association of Physicians·2015
Same author

Trends in mortality after first hospitalization with atrial fibrillation diagnosis in Sweden 1987 to 2006.

International journal of cardiology·2014
Same author

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.

International journal of cardiology·2013
Same author

The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.

International journal of obesity (2005)·2013
Same author

Effect of nesiritide in patients with acute decompensated heart failure.

The New England journal of medicine·2011
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Beta blockers like practolol and alprenolol significantly improved heart function in patients with dilated congestive cardiomyopathy (DCCM). These findings suggest beta blockade therapy is valuable for treating DCCM.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Idiopathic dilated congestive cardiomyopathy (DCCM) presents challenges in treatment, often involving refractory symptoms like resting tachycardia.
  • The role of beta-adrenergic blockade in myocardial protection gained interest in the early 1970s.

Purpose of the Study:

  • To investigate the efficacy of beta-blocker therapy in patients with advanced idiopathic dilated congestive cardiomyopathy.
  • To assess the impact of specific beta blockers on cardiac function and symptomatology in DCCM.

Main Methods:

  • Initial case report of intravenous practolol and alprenolol in a patient with DCCM.
  • A subsequent study involving oral practolol (50-400 mg twice daily) for 2-12 months in 6 DCCM patients.
  • An open-label follow-up study in 1980 with 28 DCCM patients receiving alprenolol, metoprolol, practolol, or propranolol.

Related Experiment Videos

Main Results:

  • Dramatic improvement in a patient's condition following initial intravenous beta-blocker administration.
  • Improved ventricular function observed in all 6 patients receiving oral practolol.
  • Treatment with various beta blockers in 28 DCCM patients was associated with enhanced myocardial function and symptom relief.
  • Observed improvements were reversible upon drug withdrawal, indicating a direct effect of beta-blockade.

Conclusions:

  • Beta-blocker therapy demonstrates potential value in the management of idiopathic dilated congestive cardiomyopathy.
  • Practolol, alprenolol, metoprolol, and propranolol showed promise in improving cardiac function and symptoms in DCCM patients.
  • Further investigation into beta-blockade for DCCM treatment is warranted based on these findings.